These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1815070)

  • 1. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
    Lui CY; Amidon GL; Goldberg A
    J Pharm Sci; 1991 Dec; 80(12):1125-9. PubMed ID: 1815070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.
    Greenblatt DJ; Harmatz JS; Engelhardt N; Shader RI
    Arch Gen Psychiatry; 1989 Apr; 46(4):326-32. PubMed ID: 2564763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary report on the blood levels of Flurazepam administered in two different pharmaceutical formulations].
    Ghirardi P; Marzo A; Parenti MA; Grosso F
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):167-70. PubMed ID: 17955644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.
    Henry RJ; Ruano N; Casto D; Wolf RH
    Pediatr Dent; 1998; 20(5):321-6. PubMed ID: 9803431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.
    Ellinwood E; Linnoila M; Marsh G
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):68S-75S. PubMed ID: 2229465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of triazolam and midazolam in human plasma using gas chromatography with microelectron capture detection for clinical application].
    Tsutsumi K; Iwao M; Kotegawa T; Imai H; Ohashi K; Nakano S
    Yakugaku Zasshi; 2014; 134(1):119-25. PubMed ID: 24389624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients.
    Björkman S; Rigemar G; Idvall J
    Br J Anaesth; 1997 Nov; 79(5):575-80. PubMed ID: 9422893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
    Ochs HR; Greenblatt DJ; Eichelkraut W; Bakker C; Göbel R; Hahn N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):852-6. PubMed ID: 3694534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
    J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo.
    Sunshine A
    Clin Pharmacol Ther; 1975 May; 17(5):573-7. PubMed ID: 236108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of triazolam following sublingual versus oral administration.
    Scavone JM; Greenblatt DJ; Friedman H; Shader RI
    J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Midazolam as an Intranasal Sedative in Dentistry.
    Greaves A
    SAAD Dig; 2016 Jan; 32():46-9. PubMed ID: 27145560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of midazolam in children following intranasal administration.
    Walbergh EJ; Wills RJ; Eckhert J
    Anesthesiology; 1991 Feb; 74(2):233-5. PubMed ID: 1990898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of a novel midazolam gel after intranasal administration in dogs.
    Eagleson JS; Platt SR; Strong DL; Kent M; Freeman AC; Nghiem PP; Zheng B; White CA
    Am J Vet Res; 2012 Apr; 73(4):539-45. PubMed ID: 22452501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of patient age and physician training on choice and dose of benzodiazepine hypnotic drugs.
    Shorr RI; Bauwens SF
    Arch Intern Med; 1990 Feb; 150(2):293-5. PubMed ID: 2302005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of midazolam after i.v., nasal or rectal administration in children.
    Malinovsky JM; Lejus C; Servin F; Lepage JY; Le Normand Y; Testa S; Cozian A; Pinaud M
    Br J Anaesth; 1993 Jun; 70(6):617-20. PubMed ID: 8329252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs.
    Bowen AJ
    J Int Med Res; 1978; 6(4):337-42. PubMed ID: 28989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the sedative effect of oral versus nasal midazolam combined with nitrous oxide in uncooperative children.
    Musani IE; Chandan NV
    Eur Arch Paediatr Dent; 2015 Oct; 16(5):417-24. PubMed ID: 25939638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.